The spectrum of cervical diseases induced by low-risk and undefined-risk HPVs: Implications for patient management

Anticancer Research

Volumn 27, Issue 1 B, 2007, Pages 563-570

  Várnai, Alinda D ^a   Bollmann, Magdolna ^a   Bánkfalvi, Ágnes ^b   Griefingholt, Harald ^a   Pfening, Natalie ^a   Schmitt, Christoph ^c   Pajor, László ^d   Bollmann, Reinhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c Institute of Molecular Pathology and Gene Diagnostics (ImoGen GmbH)   (Germany)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Cervical screening; HPV genotyping; Non classical HPV sings

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CANCER SCREENING; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT CARE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING; SEQUENCE ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VERRUCA VULGARIS; VIRUS INFECTION; WART VIRUS;

DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; POLYMERASE CHAIN REACTION; RISK FACTORS; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL DISEASES; VAGINAL SMEARS;

EID: 33847757492     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999.
2. Bosch FX, Lorincz A, Munoz N Meijer CJ and Shah KV: The causal relation between Human Papillomavirus and cervical cancer. J Clin Pathol 55: 244-265, 2002.
3. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ and Meijer CJ; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003.
4. Bulkmans NW, Bleeker MC, Berkhof J, Voohosrt FJ, Snijders PJ and Meijer CP: Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse. Int J Cancer 117: 177-181, 2005.
5. Soost HJ: Befundwiedergabe in der gynäkologischen Zytodiagnostik - Münchener Nomenklatur II. Gynäkol Prax 14: 433-438, 1990.
6. Bollmann M, Bánkfalvi A, Trosic A, Speich N, Schmitt C and Bollmann R: Can we detect cervical human papillomavirus (HPV) infection by cytomorphology alone? Diagnostic value of non-classic cytological signs of HPV effect in minimally abnormal Pap tests. Cytopathology 16: 13-21, 2005.
7. Speich N, Schmitt C, Bollmann R and Bollmann M: Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the West German area. J Med Microbiol 53: 125-128, 2004.
8. de Villiers EM, Fauquet C, Broker TR, Bernard HU and zur Hausen H: Classification of papillomaviruses. Virology 324: 17-27, 2004.
9. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE and Burk RD: The carcinogenicity of human papillomavirus types reflects viral evolution. Virology, 337: 76-84, 2005.
10. Meyer T, Arndt R, Beckmann ER, Padberg B, Christophers E and Stockfleth E: Distribution of HPV 53, HPV 73 and CP8304 in genital epithelial lesions with different grades of dysplasia. Int J Gynecol Cancer 11: 198-204, 2001.
11. Snijders PJF, Steenbergen RDM. Heideman DAM and Meijer CJLM: HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 208: 152-164, 2006.
12. Schneider A, Meinhardt G, de Villiers EM and Gissmann L: Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV DNA hybridization studies. Diagn Cytopathol 3: 250-255, 1987.
13. Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Carbillet JP, Lassabe C, Arveux P, Seilles E and Mougin C: Genital human papillomavirus infection among women recruited for routine cervical cancer screening for colposcopy determined by hybrid capture II and polymerase chain reaction. Diagn Mol Pathol 8: 157-164, 1999.
14. Meyer T, Arndt R, Christophers E, Beckmann ER, Schröder S, Gissmann L and Stockfleth E: Association of rare human papillomavirus types with genital premalignant and malignant lesions. J Infect Dis 178: 252-255, 1988.
15. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ and Wheeler CM: Determinants of genital human papillomavirus detection in a US population. J Infect Dis 183: 1554-1564, 2001.
16. Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A and Manos MM: Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis 20: 286-289, 1993.
17. Cecchini S, Confortini M, Bonardi L, Cipparrone G, Galante L, Iossa A and Ciatto S: "Nonclassic" cytologic signs of cervical condyloma. Acta Cytol 6: 781-784, 1990.
18. Cramer HM, Skinner-Wannemuehler SE, Brown DR, Katz BP and Fife KH: Cytomorphologic correlates of human papillomavirus infection in the "normal" cervicovaginal smear. Acta Cytol 41: 261-268, 1997.
19. Rozendaal L, Walboomers JM, van der Linden JC, Walboomers JM, Voorhorst FJ, Risse EK, Boon ME and Meijer CJ: PCR based high risk HPV testing is superior to neural network based screening for predicting incident CINIII in women with normal cytology and borderline changes. J Clin Pathol 53: 606-611, 2000.
20. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G and Dillner J: Type-specific persistence of human papillomavirus DNA before the developments of invasive cervical cancer. N Engl J Med 341: 1633-1638, 1999.
21. Nobbenhuis MA, Heimerhorst TJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Bezemer D, Verheijen RH and Meijer CJ: Cytological regression and clearence of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358: 1782-1783, 2001.
22. Cox JT, Schiffman M and Solomon D: Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 188: 1406-1412, 2003.
23. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM and Wheeler CM: Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence and phylogenetic algorithms. J Infect Dis 170: 1077-1085, 1994.
24. Kahn T, Schwarz E and zur Hausen H: Molecular cloning and characterization of the DNA of a new human papillomavirus (HPV 30) from a laryngeal carcinoma. Int J Cancer 37: 61-65, 1986.